Preventing rejection, minimizing toxicity: optimized therapy with cyclosporin
MMWFortschrittederMedizin 144(3-4): 59
2002
ISSN/ISBN: 1438-3276 PMID: 11862796 Document Number: 542856
Document emailed within 1 workday
Related Documents
Xi, X-hua.; Qin, B.; Jiang, D-yong. 2003: Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty Hunan Yi Ke da Xue Xue Bao 28(6): 627-630Felder, R.A.; Mifflin, T.E.; Bastani, B. 1986: An optimized method for measuring cyclosporin a with 125I-labeled cyclosporin Clinical Chemistry 32(7): 1378-1382
Filingeri, V.; Rosati, R.; Sconocchia, G.; Pisani, A.; Vennarecci, G.; Anselmo, A.; Pepe, N.; Barletta, N.; Casciani, C.U. 1995: Synergism between cyclosporin and gangliosides in anti-rejection therapy. Experimental in vivo model Minerva Chirurgica 50(3): 275-278
Matl, I.; Gintelová, J.; Jirka, J.; Rossmann, P. 1993: Graft rejection after changing from cyclosporin A therapy to conventional treatment in kidney transplant patients Casopis Lekaru Ceskych 132(10): 301-304
Avery, J.K. 1985: Our goal: preventing or minimizing patient injury Journal of the Tennessee Medical Association 78(4): 232-233
Barwitz, H.J. 1999: Sore throat in general practice. Minimizing diagnosis--preventing superfluous use of antibiotics MMW Fortschritte der Medizin 141(44): 28-31
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793
Rossmann, P.; Jirka, J.; Zástava, V.; Reneltová, I.; Kocandrle, V. 1986: Rejection nephropathy before and after therapeutic administration of cyclosporin a Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 132(5-6): 435-458
García, R.; Zschaeck, D.; Ogeerally, J.; Domínguez, J.; Rodríguez-Iturbe, B. 1989: Discontinuation of cyclosporin with low incidence of rejection in human renal transplantation Clinical Nephrology 32(1): 46-47
Merion, R.M.; White, D.J.; Calne, R.Y. 1983: Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression Transplantation Proceedings 15(4): 2172-2177
Beckingham, I.J.; O'Rourke, J.S.; Stubington, S.R.; Hinwood, M.; Bishop, M.C.; Rigg, K.M. 1997: Impact of cyclosporin on the incidence and prevalence of chronic rejection in renal transplants Annals of the Royal College of Surgeons of England 79(2): 138-142
Thiel, G.; Torhorst, J.; Brunner, F.P. 1980: Renal toxicity of cyclosporin a in the rat Proceedings of the Clinical Dialysis and Transplant Forum 10: 62-66
Klintmalm, G. 1987: Development of chronic renal cyclosporin-A toxicity Nephrologie 8(3): 131-133
Zhang, A-bin.; Zheng, S-sen.; Jia, C-ku.; Wang, Y. 2004: Role of 1,25-dihydroxyvitamin D3 in preventing acute rejection of allograft following rat orthotopic liver transplantation Chinese Medical Journal 117(3): 408-412
Mihatsch, M.J.; Ryffel, B.; Gudat, F. 1995: The differential diagnosis between rejection and cyclosporine toxicity Kidney International. Suppl 52: S63-S69
Li, Z-dong.; Shi, C-qing.; Zhang, Q-hua.; Xiong, Y-liang.; Zhou, X-ding.; Wang, W-yu.; Song, N. 2004: Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats Zhonghua Yi Xue Za Zhi 84(23): 2007-2010
Akamatsu, H.; Tsukuura, T.; Matsunaga, H.; Suzuki, A. 1993: Study of combination therapy for thymoma: a case of stage IV which presented as total spinal block caused by epidural metastasis and which preoperative combination therapy was effective for minimizing the tumor Kyobu Geka. Japanese Journal of Thoracic Surgery 46(13): 1156-1160
2014: Vitamin K antagonists. Long-term therapy optimized by coagulation self management MMW Fortschritte der Medizin 156(10): 78-79
Guo, Z.; Mital, D.; Shen, J.; Chong, A.S.; Tian, Y.; Foster, P.; Sankary, H.; McChesney, L.; Jensik, S.C.; Williams, J.W. 1998: Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice Transplantation 65(10): 1310-1314
Dousa, M.K.; Moore, S.B.; Ploeger, N.A.; DeGoey, S.R.; Dousa, T.P. 1997: Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE 3 and PDE 4 suppress lymphoblastic response to HLA class II alloantigens: a potential novel approach to preventing allograft rejection? Clinical Nephrology 47(3): 187-189